More Kiwis using long-acting contraception

Publicly released:
New Zealand
Photo by Reproductive Health Supplies Coalition
Photo by Reproductive Health Supplies Coalition

There has been a significant increase in the use of long-acting reversible contraceptives like implants or IUDs by Family Planning clients between 2009 and 2019. New research shows that the increase was matched by a significant decrease in short-acting contraceptives such as the pill. It also showed that while cost of the contraceptive is a clear barrier to using it, there are other differences in contraceptive choice by ethnicity and poverty that cannot be explained by cost alone.

Media release

From: New Zealand Medical Association (NZMA)

Key Points

  • There have been significant changes in contraceptive starts among Family Planning clients over the past decade.
  • There has been a significant increase in long-acting reversible contraceptive (LARC) starts and a significant decrease in short-acting contraceptive starts between 2009 and 2019.
  • This research shows that cost of the contraceptive is a barrier to use.
  • Although cost is a clear barrier, this research shows there are other differences in contraceptive starts by ethnicity and deprivation which cannot be explained by cost alone.
  • Information about contraceptive use and changes over time, by age and ethnicity, is essential for evidence-based policy, funding decisions and ensuring equitable access to contraception.

Summary
This research investigates changes in what contraceptives Family Planning clients chose to use in 2009, 2014 and 2019. The research found that clients in 2019 were more likely to use long-acting reversible contraceptives (eg, an implant or Mirena) than short-acting reversible contraceptives (eg, the pill or Depo Provera) as compared to 2009. The research found that if a contraceptive were free, clients would be more likely to choose it, but also, that there would be differences in what contraceptives were chosen based on ethnic group and poverty level that did not relate to whether the contraceptive was free or not. We need more information about what contraceptives people choose to use, and why, so we can make sure everyone can access what is best for them.

Journal/
conference:
New Zealand Medical Journal
Organisation/s: University of Otago, Family Planning New Zealand, Te Whāriki Takapou
Funder: Competing interests: Beth Messenger, Amy Beliveau and Mike Clark report they are employees of Family Planning. Beth Messenger also reports she is Chair of the New Zealand College of Sexual and Reproductive Health, and that she was a member of the Ministry of Health National Contraception Guidelines Steering Group.
Media Contact/s
Contact details are only visible to registered journalists.